Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04933617 2024-07-09

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

Phase 1 Terminated

8 enrolled 17 charts

Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT04840615 2024-02-02

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Phase 1 Terminated

2 enrolled 14 charts

Other solid neoplasmThoracic

Mesothelioma

NCT01225757 2023-08-14

Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC

Phase NA Withdrawn

Gynecologic

Peritoneal Neoplasms

NCT03940625 2022-05-25

ANKE

Phase NA Completed

69 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT03295695 2020-12-04

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT04461392 2020-07-08

Exercise Response After Revalidation in Cancer Patients

Phase NA Unknown

191 enrolled

Neoplasms, Cardiotoxicity

NCT02543294 2020-02-05

REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)

Phase NA Completed

20 enrolled 9 charts

Heart Failure

Clinical Trials

A Study of Blood Pressure Control During Cancer Treatment

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

Treatment and Natural History Study of Lymphomatoid Granulomatosis

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies